Innoviva (INVA) Gains from Investment Securities (2009 - 2026)
Innoviva posted quarterly Gains from Investment Securities of $158000.0 for Q1 2026, down 81.84% on a QoQ basis from $870000.0 in Q4 2025.
Innoviva (INVA) has 18 years of Gains from Investment Securities data on file, last reported at $158000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities changed N/A year-over-year to $158000.0; the trailing twelve-month figure through Mar 2026 stood at $365000.0 (up 32.25% YoY), and the FY2025 full-year result was $870000.0, down 57.91% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $158000.0, down from $870000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $3.3 million in Q3 2022 and bottomed at -$1.4 million in Q2 2024.
- The 5-year median for Gains from Investment Securities is $119500.0 (2024), against an average of $468437.5.
- The widest annual swing landed in 2022, when Gains from Investment Securities plunged 1307.32%; it then jumped 6478.26% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $948000.0 in 2022, then surged by 58.12% to $1.5 million in 2023, then jumped by 37.89% to $2.1 million in 2024, then plunged by 57.91% to $870000.0 in 2025, then plunged by 81.84% to $158000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $158000.0 (Q1 2026), $870000.0 (Q4 2025), and $116000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 158,000.00 |
| Mar 31, 2026 | 158,000.00 |
| Dec 31, 2025 | 870,000.00 |
| Dec 31, 2025 | 870,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Dec 31, 2024 | 2.07 Mn |
| Dec 31, 2024 | 2.07 Mn |
| Sep 30, 2024 | 123,000.00 |
| Sep 30, 2024 | 123,000.00 |
| Jun 30, 2024 | -1.36 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 65,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Jun 30, 2023 | -1.08 Mn |
| Jun 30, 2023 | -1.08 Mn |
| Mar 31, 2023 | 23,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 948,000.00 |
| Dec 31, 2022 | 948,000.00 |
| Sep 30, 2022 | 3.32 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | -577,000.00 |
| Jun 30, 2022 | -577,000.00 |
| Mar 31, 2022 | -280,000.00 |
| Mar 31, 2022 | -280,000.00 |
| Dec 31, 2021 | 766,000.00 |
| Dec 31, 2021 | 766,000.00 |
| Sep 30, 2021 | 178.40 Mn |
| Sep 30, 2021 | 178.40 Mn |
| Jun 30, 2021 | -41,000.00 |
| Jun 30, 2021 | -41,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Dec 31, 2020 | 106,000.00 |
| Dec 31, 2020 | 106,000.00 |
| Dec 31, 2019 | 104,000.00 |
| Dec 31, 2019 | 104,000.00 |
| Sep 30, 2019 | -178,000.00 |
| Sep 30, 2019 | -178,000.00 |
| Jun 30, 2019 | 9,000.00 |
| Jun 30, 2019 | 9,000.00 |
| Mar 31, 2019 | 65,000.00 |
| Mar 31, 2019 | 65,000.00 |
| Dec 31, 2018 | 3.07 Mn |
| Dec 31, 2018 | 3.07 Mn |
| Sep 30, 2018 | -2.84 Mn |
| Sep 30, 2018 | -2.84 Mn |
| Jun 30, 2018 | 229,000.00 |
| Jun 30, 2018 | 229,000.00 |
| Mar 31, 2018 | 2.61 Mn |
| Mar 31, 2018 | 2.61 Mn |
| Dec 31, 2017 | -1.18 Mn |
| Dec 31, 2017 | -1.18 Mn |
| Sep 30, 2017 | 336,000.00 |
| Sep 30, 2017 | 336,000.00 |
| Jun 30, 2017 | 294,000.00 |
| Jun 30, 2017 | 294,000.00 |
| Mar 31, 2017 | 553,000.00 |
| Mar 31, 2017 | 553,000.00 |
| Dec 31, 2016 | -29,000.00 |
| Dec 31, 2016 | -29,000.00 |
| Sep 30, 2016 | 885,000.00 |
| Sep 30, 2016 | 885,000.00 |
| Jun 30, 2016 | 200,000.00 |
| Jun 30, 2016 | 200,000.00 |
| Mar 31, 2016 | 442,000.00 |
| Mar 31, 2016 | 442,000.00 |
| Dec 31, 2015 | -18.45 Mn |
| Dec 31, 2015 | -18.45 Mn |
| Sep 30, 2015 | 5.60 Mn |
| Sep 30, 2015 | 5.60 Mn |
| Jun 30, 2015 | 6.40 Mn |
| Jun 30, 2015 | 6.40 Mn |
| Dec 31, 2014 | -2,000.00 |
| Dec 31, 2014 | -2,000.00 |
| Sep 30, 2014 | 2.96 Mn |
| Sep 30, 2014 | 2.96 Mn |
| Mar 31, 2014 | 2.93 Mn |
| Mar 31, 2014 | 2.93 Mn |
| Sep 30, 2013 | 3.67 Mn |
| Sep 30, 2013 | 3.67 Mn |
| Jun 30, 2013 | 28,000.00 |
| Jun 30, 2013 | 28,000.00 |
| Mar 31, 2013 | 423,575.00 |
| Mar 31, 2013 | 423,575.00 |
| Dec 31, 2012 | -195,000.00 |
| Dec 31, 2012 | -195,000.00 |
| Sep 30, 2012 | 476,977.00 |
| Sep 30, 2012 | 476,977.00 |
| Mar 31, 2012 | 556,546.00 |
| Mar 31, 2012 | 556,546.00 |
| Dec 31, 2011 | 63,000.00 |
| Dec 31, 2011 | 63,000.00 |
| Sep 30, 2011 | 1.17 Mn |
| Sep 30, 2011 | 1.17 Mn |
| Jun 30, 2011 | 1.15 Mn |
| Jun 30, 2011 | 1.15 Mn |
| Mar 31, 2011 | 394,580.00 |
| Mar 31, 2011 | 394,580.00 |
| Dec 31, 2010 | 7.65 Mn |
| Dec 31, 2010 | 7.65 Mn |
| Dec 31, 2009 | 8.41 Mn |
| Dec 31, 2009 | 8.41 Mn |